181 related articles for article (PubMed ID: 38391911)
1. Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis.
Shao J; Olsen RJ; Kasparian S; He C; Bernicker EH; Li Z
Cells; 2024 Feb; 13(4):. PubMed ID: 38391911
[TBL] [Abstract][Full Text] [Related]
2. 5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer.
Shao J; Xu Y; Olsen RJ; Kasparian S; Sun K; Mathur S; Zhang J; He C; Chen SH; Bernicker EH; Li Z
Cells; 2024 Apr; 13(8):. PubMed ID: 38667328
[TBL] [Abstract][Full Text] [Related]
3. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia.
Shao J; Wang S; West-Szymanski D; Karpus J; Shah S; Ganguly S; Smith J; Zu Y; He C; Li Z
Sci Rep; 2022 Jul; 12(1):12410. PubMed ID: 35859008
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
Chiu BC; Zhang Z; You Q; Zeng C; Stepniak E; Bracci PM; Yu K; Venkataraman G; Smith SM; He C; Zhang W
Blood Adv; 2019 Oct; 3(19):2790-2799. PubMed ID: 31570490
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
[TBL] [Abstract][Full Text] [Related]
6. Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer.
Hu X; Luo K; Shi H; Yan X; Huang R; Zhao B; Zhang J; Xie D; Zhang W
Clin Epigenetics; 2022 Jan; 14(1):15. PubMed ID: 35073982
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
[TBL] [Abstract][Full Text] [Related]
10. Cell-free DNA 5-hydroxymethylcytosine profiles of long non-coding RNA genes enable early detection and progression monitoring of human cancers.
Zhou M; Hou P; Yan C; Chen L; Li K; Wang Y; Zhao J; Su J; Sun J
Clin Epigenetics; 2021 Oct; 13(1):197. PubMed ID: 34689838
[TBL] [Abstract][Full Text] [Related]
11. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients.
Chen HY; Zhang WL; Zhang L; Yang P; Li F; Yang ZR; Wang J; Pang M; Hong Y; Yan C; Li W; Liu J; Xu N; Chen L; Xiao XB; Qin Y; He XH; Liu H; Zhu HC; He C; Lin J; Jing HM
Clin Epigenetics; 2021 Feb; 13(1):33. PubMed ID: 33573703
[TBL] [Abstract][Full Text] [Related]
13. 5hmC-MIQuant: Ultrasensitive Quantitative Detection of 5-Hydroxymethylcytosine in Low-Input Cell-Free DNA Samples.
Yuan F; Yu Y; Zhou YL; Zhang XX
Anal Chem; 2020 Jan; 92(1):1605-1610. PubMed ID: 31829563
[TBL] [Abstract][Full Text] [Related]
14. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease.
Chu JL; Bi SH; He Y; Ma RY; Wan XY; Wang ZH; Zhang L; Zheng MZ; Yang ZQ; Du LW; Maimaiti Y; Biekedawulaiti G; Duolikun M; Chen HY; Chen L; Li LL; Tie L; Lin J
Front Endocrinol (Lausanne); 2022; 13():910907. PubMed ID: 35966076
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease.
Dong C; Chen J; Zheng J; Liang Y; Yu T; Liu Y; Gao F; Long J; Chen H; Zhu Q; He Z; Hu S; He C; Lin J; Tang Y; Zhu H
Clin Epigenetics; 2020 Jan; 12(1):17. PubMed ID: 31964422
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.
Song CX; Yin S; Ma L; Wheeler A; Chen Y; Zhang Y; Liu B; Xiong J; Zhang W; Hu J; Zhou Z; Dong B; Tian Z; Jeffrey SS; Chua MS; So S; Li W; Wei Y; Diao J; Xie D; Quake SR
Cell Res; 2017 Oct; 27(10):1231-1242. PubMed ID: 28820176
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer.
Zhang J; Han X; Gao C; Xing Y; Qi Z; Liu R; Wang Y; Zhang X; Yang YG; Li X; Sun B; Tian X
Genomics Proteomics Bioinformatics; 2018 Jun; 16(3):187-199. PubMed ID: 30010036
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer.
Weigert M; Cui XL; West-Szymanski D; Yu X; Bilecz AJ; Zhang Z; Dhir R; Kehoe M; Zhang W; He C; Lengyel E
Gynecol Oncol; 2024 Mar; 182():82-90. PubMed ID: 38262243
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer.
Storebjerg TM; Strand SH; Høyer S; Lynnerup AS; Borre M; Ørntoft TF; Sørensen KD
Clin Epigenetics; 2018 Aug; 10(1):105. PubMed ID: 30086793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]